Artesunate combinations for treatment of malaria: Meta-analysis

Lancet

Volumn 363, Issue 9402, 2004, Pages 9-17

  Garner, P ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMISIN; ARTESUNATE; CHLOROQUINE; FANSIDAR; MEFLOQUINE; PLACEBO;

ARTICLE; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; GAMETOCYTE; HUMAN; MALARIA; MEDICAL ASSESSMENT; META ANALYSIS; PHYSICAL DISEASE BY BODY FUNCTION; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REDUCTION; REINFECTION; RISK; SIDE EFFECT; STANDARD;

EID: 0347285290     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)15162-8     Document Type: Article

References (27)

1. Breman J.G., Egan A., Keusch G.T. The intolerable burden of malaria: a new look at the numbers. Am J Trop Med Hyg. 64(suppl):2001;4-7i.
2. Snow R.N., Craig M., Deichmann U., Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ. 77:1999;624-640.
3. Trape J.F., Pison G., Preziosi M.P., et al. Impact of chloroquine resistance on malaria morbidity. CR Acad Sci Paris Ser III. 321:1998;689-697.
4. White N.J., Nosten F., Looareesuwan S., et al. Averting a malaria disaster. Lancet. 353:1999;1965-1967.
5. White N.J. Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci. 354:1999;739-749.
6. Price R.N., Nosten F. Drug resistant falciparum malaria: clinical consequences and strategies for prevention. Drug Resist Update. 4:2001;187-196.
7. White N.J. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother. 41:1997;1413-1422.
8. Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996; 15; 347: 1654-58.
9. Targett G., Drakeley C., Jawara M., et al. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis. 183:2001;1254-1259.
10. Nosten F., van Vugt M., Price R., et al. Effects of artesunate- mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 356:2000;297-302.
11. Olliaro P., Taylor W.R., Rigal J. Controlling malaria: challenges and solutions. Trop Med Int Health. 6:2001;922-927.
12. Stewart L.A., Clarke M. Practical methodology of meta-analyses (overviews) using updated individual patient data. Stats Med. 14:1995;2057-2079.
13. White N, Greenwood B, Watkins BM, et al. Randomized, double blind, placebo controlled study of the tolerability and efficacy of artesunate plus combinations vs. single agent for the treatment of uncomplicated malaria. Generic trial protocol. Geneva: Special Programme for Research and Training in Tropical Diseases (TDR), 1998: unpublished document. http://www.liv.ac.uk/lstm/ ehcap/CIDG/art-combo_protocol.pdf (accessed Nov 10, 2003).
14. Adjuik M., Agnamey P., Babiker A., et al. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet. 359:2002;1365-1372.
15. von Seidlein L., Milligan P., Pinder M., et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet. 355:2000;352-357.
16. International Artemisinin Study Group. Artesunate combinations for treating uncomplicated malaria: a prospective individual patient data meta-analysis - protocol for a Cochrane Review. In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
17. Dorsey G., Njama D., Kamya M.R., et al. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet. 360:2002;2031-2038.
18. Nosten F., Luxemburger C., ter Kuile F.O., et al. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J Infect Dis. 170:1994;971-977.
19. Price R.N., Nosten F., Luxemburger C., et al. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg. 89:1995;523-527.
20. Snounou G., Beck H.P. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Parasitol Today. 14:1998;462-467.
21. Taylor WRJ, Adjuik M, Olliaro P, Garner P, Babiker A. Analysis plan for combination studies. Geneva: Special Programme for Research and Training in Tropical Diseases (TDR), 1998. Unpublished document. http://www.liv.ac.uk/lstm/ ehcap/CIDG/artcombo_analysisplan.pdf (accessed Nov 10, 2003).
22. Early Breast Cancer Trialists' Collaborative Group. Treatment of early breast cancer: volume 1 - worldwide evidence 1985-1990. Oxford: Oxford University Press, 1990.
23. Mantel N., Haenzel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst. 22:1959;719-748.
24. De Mets D.L. Methods for combining randomised clinical trials: Strengths and limitations. Stats Med. 6:1987;341-3348.
25. Peto R. Why do we need systematic overviews of randomised trials? Stats Med. 6:1987;233-240.
26. Lau J., Ioannidis J., Schmid C. Summing up evidence: one answer is not always enough. Lancet. 351:1998;123-127.
27. Sharp S. Meta-analysis regression. Stata Tech Bull. 42:1998;16-22.